about
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte deathEpigenetics: a new mechanism of regulation of heart failure?Methodological challenges in utilizing miRNAs as circulating biomarkersThe L-type Ca2+ channels blocker nifedipine represses mesodermal fate determination in murine embryonic stem cells.Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cellsLoss of MicroRNA-155 protects the heart from pathological cardiac hypertrophyMolecular mechanisms and clinical applications of angiogenesisCardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart.MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancerMicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells.Epigenetics: an expanding new piece of the stroke puzzleMiR-486 regulates cardiomyocyte apoptosis by p53-mediated BCL-2 associated mitochondrial apoptotic pathway.Assessment of coronary microvascular resistance in the chronic infarcted pig heart.Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy.MicroRNA miR-92a-1 biogenesis and mRNA targeting is modulated by a tertiary contact within the miR-17~92 microRNA clusterE2F1-regulated miR-30b suppresses Cyclophilin D and protects heart from ischemia/reperfusion injury and necrotic cell deathmiR-361-regulated prohibitin inhibits mitochondrial fission and apoptosis and protects heart from ischemia injury.Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.Epigenetic modifications in cardiovascular disease.Common variants in TGFBR2 and miR-518 genes are associated with hypertension in the Chinese populationmiR-874 regulates myocardial necrosis by targeting caspase-8.Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.Circles reshaping the RNA world: from waste to treasure.Circulating microparticles: new insights into the biochemical basis of microparticle release and activity.Therapeutic neovascularization for coronary disease: current state and future prospects.Molecular advances in reporter genes: the need to witness the function of stem cells in failing heart in vivo.Eccentric and concentric cardiac hypertrophy induced by exercise training: microRNAs and molecular determinants.The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury.Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension.Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.MicroRNAs as novel regulators of stem cell fate.The role of microRNAs in cardiovascular disease.Heart failure with preserved ejection fraction: a clinical dilemma.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation.Inflammation and vascular smooth muscle cell dedifferentiation following carotid artery ligation.MicroRNAs-control of essential genes: Implications for pulmonary vascular disease.Live monitoring of small vessels during development and disease using the flt-1 promoter element.
P2860
Q26995349-22ADAB20-EDBA-4D46-AB49-F241FA8F3D30Q27013611-0C6A673E-801E-4B10-B2B2-A31AB9963715Q27027950-961CD024-2833-4E60-82DD-3A3DE7CC53DFQ27321569-347552BE-755E-451C-BDF9-AFB46FF29BFDQ28271151-F228230E-37F5-4014-ADB4-64EAD2287679Q28565486-C1E75531-9D80-4666-A712-F302F93D6BFCQ29547314-F121887D-1944-4404-8AFD-7C9A10BA3E8DQ30528601-85D0E432-F938-4C62-909D-722AAF22AC52Q31037470-BB00CD33-62A4-4354-8B66-B618155EA04BQ32884452-4DB59FB3-4F81-42B4-B318-6FA059CAE954Q33352309-EAFC657A-D673-43AC-878D-7F5FB31CF4C2Q33655009-32596962-2356-4EC3-8AB6-4325999DD33CQ33985618-EA10ECA9-B179-4FC1-91D9-1483AECAA718Q34158605-91BA7A06-E972-4C2C-A15C-5D0D6067EA3AQ34403761-DA3BE7F5-F0E1-4D60-8C2E-BAB06FE9BC4EQ35349455-0068EB84-1E9B-42C0-B474-5E53146CB420Q35579312-85D2B7C0-B8D9-496A-A7E6-3ACC78211670Q35643799-A1E2422E-6099-4294-BC8A-BBDB068A1436Q35898458-0B8999AC-2B99-4265-ADBF-084E9A0C267CQ36750422-A6630080-23FA-4B90-B6F2-34720EBDFB1DQ37062013-81E10A06-1A7B-4C16-A9D4-ADAA765F8DA0Q37294594-A495B7FB-3366-4517-AC13-C4E8439C8FDEQ37294951-94D0B28C-F245-475E-95AD-33EE85860317Q37692556-4E946344-2C72-4469-ACFC-A0439F2B7DFFQ37892456-27FCE694-FC79-4189-891A-B38D33EB4901Q37895528-3FAB7294-A826-4CA4-8B1A-15E0BEAEDBADQ37898029-9223D6ED-AEDB-462F-AAE6-16C219FC2DA7Q37924622-3A3735A5-8157-4362-AE79-6D8C1599A881Q37926558-335A454B-8FD9-40CC-A5B1-E62C0CCCC1CEQ37939725-009D80FE-316B-46B6-B7AA-F097EFF0F06BQ37973261-90692E26-729D-4820-8A66-42C4D1009EDAQ38157933-D6B037F1-03F8-4F27-B9CD-2705A1AA4691Q38189405-AE02636F-8744-4350-B958-9BC992697B92Q38195149-5CC18F6D-2D43-4E2D-8EB1-37ECC67D3E8FQ38217461-BB6F6B68-B32A-426A-925D-259A7742F201Q38665806-DCB2C09A-77F5-4641-AAEE-5D0DA3EAA3D9Q38926005-2547314B-A201-4742-A1A8-F139E9327E39Q39048502-71D89B2E-822C-415D-B2B0-571E4B0B4088Q39385085-76B94F4E-BF0F-44DC-98D2-A898AC114688Q39387425-E29AFDE0-DF22-44CF-A40A-0A24E731BA3E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Control of cardiovascular differentiation by microRNAs.
@en
Control of cardiovascular differentiation by microRNAs.
@nl
type
label
Control of cardiovascular differentiation by microRNAs.
@en
Control of cardiovascular differentiation by microRNAs.
@nl
prefLabel
Control of cardiovascular differentiation by microRNAs.
@en
Control of cardiovascular differentiation by microRNAs.
@nl
P1476
Control of cardiovascular differentiation by microRNAs.
@en
P2093
Kisho Ohtani
P2888
P356
10.1007/S00395-010-0139-7
P577
2010-12-24T00:00:00Z